One in 3 stent implants in India is possibly unnecessary

Posted on August 12th, 2020 by Seshu Narayana

Several senior cardiologists in India have raised concern over rise in the cases of unnecessary implant of stents in India. They say if an audit of stent implant cases was done, over a third of the elective procedures could turn out to be needless. A few years ago in the US, which has better monitoring […]

Read More

Focus shifts to expensive pacemakers, lenses, catheters

Posted on August 11th, 2020 by Seshu Narayana

After the capping of cardiac stent prices, the Rajya Sabha petitions committee has turned its attention to overpricing of other medical devices. On Tuesday, the committee heard the National Pharmaceutical Pricing Authority (NPPA) and the department of pharmaceuticals (DoP) on the issue.  The health ministry has classified 22 medical devices, including cardiac stents, as drugs […]

Read More

The National Pharmaceutical Pricing Authority (NPPA) Monday further slashed prices of the expensive cardiac stents while marginally increasing the cost of the basic stents. After several rounds of consultation with various stakeholders, the NPPA cut the price of drug-eluting stent (DES) by Rs 1,710 (from Rs 29,600 to Rs 27,890) while increasing the price of […]

Read More

Stents no better than drugs for many heart patients: U.S. study!!

Posted on July 14th, 2020 by Seshu Narayana

CHICAGO: Many patients with severe but stable heart disease who routinely undergo invasive procedures to clear and prop open clogged arteries would do as well by just taking medications and making lifestyle changes, reported U.S. researchers. If adopted into practice, the findings could save hundreds of millions of dollars a year in healthcare costs, researchers […]

Read More